Literature DB >> 23552512

New approaches for understanding mechanisms of drug resistance in schistosomes.

Robert M Greenberg1.   

Abstract

Schistosomes are parasitic flatworms that cause schistosomiasis, a neglected tropical disease that affects hundreds of millions worldwide. Treatment and control of schistosomiasis relies almost entirely on the single drug praziquantel (PZQ), making the prospect of emerging drug resistance particularly worrisome. This review will survey reports of PZQ (and other drug) resistance in schistosomes and other platyhelminths, and explore mechanisms by which drug resistance might develop. Newer genomic and post-genomic strategies that offer the promise of better understanding of how drug resistance might arise in these organisms will be discussed. These approaches could also lead to insights into the mode of action of these drugs and potentially provide markers for monitoring the emergence of resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552512      PMCID: PMC3775338          DOI: 10.1017/S0031182013000231

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  162 in total

1.  Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment.

Authors:  Livia Pica-Mattoccia; Donato Cioli
Journal:  Int J Parasitol       Date:  2004-03-29       Impact factor: 3.981

Review 2.  Antimalarials in the treatment of schistosomiasis.

Authors:  Jennifer Keiser; Jurg Utzinger
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Drug resistance mechanisms in helminths: is it survival of the fittest?

Authors:  Catherine E James; Amanda L Hudson; Mary W Davey
Journal:  Trends Parasitol       Date:  2009-06-21

4.  Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.

Authors:  Abdel Nasser A Sabra; Sanaa S Botros
Journal:  J Parasitol       Date:  2008-04       Impact factor: 1.276

5.  RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.

Authors:  Saša Stefanić; Jan Dvořák; Martin Horn; Simon Braschi; Daniel Sojka; Debbie S Ruelas; Brian Suzuki; Kee-Chong Lim; Stephanie D Hopkins; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-19

6.  Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility.

Authors:  Shanta M Messerli; Ravi S Kasinathan; William Morgan; Stefani Spranger; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2009-05-03       Impact factor: 1.759

7.  Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China.

Authors:  Dan-Dan Lin; Jian-Xiang Liu; Yue-Min Liu; Fei Hu; Yuan-Yuan Zhang; Jin-Mei Xu; Jian-Ying Li; Min-Jun Ji; Robert Bergquist; Guan-Ling Wu; Hai-Wei Wu
Journal:  Parasitol Int       Date:  2008-04-08       Impact factor: 2.230

Review 8.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 9.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

10.  P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.

Authors:  D J Bartley; H McAllister; Y Bartley; J Dupuy; C Ménez; M Alvinerie; F Jackson; A Lespine
Journal:  Parasitology       Date:  2009-06-24       Impact factor: 3.234

View more
  46 in total

Review 1.  Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.

Authors:  Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Fátima Gärtner; José M Correia da Costa
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.

Authors:  Gina S El-Feky; Wael S Mohamed; Hanaa E Nasr; Naglaa M El-Lakkany; Sayed H Seif El-Din; Sanaa S Botros
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

Review 3.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

Review 4.  Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.

Authors:  Afzal A Siddiqui; Sabrina Z Siddiqui
Journal:  Trends Parasitol       Date:  2016-11-16

Review 5.  Genome mining offers a new starting point for parasitology research.

Authors:  Zhiyue Lv; Zhongdao Wu; Limei Zhang; Pengyu Ji; Yifeng Cai; Shiqi Luo; Hongxi Wang; Hao Li
Journal:  Parasitol Res       Date:  2015-01-08       Impact factor: 2.289

6.  Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy.

Authors:  Alexander B Taylor; Kenneth M Roberts; Xiaohang Cao; Nathaniel E Clark; Stephen P Holloway; Enrica Donati; Chiara M Polcaro; Livia Pica-Mattoccia; Reid S Tarpley; Stanton F McHardy; Donato Cioli; Philip T LoVerde; Paul F Fitzpatrick; P John Hart
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

7.  Ion channels and drug transporters as targets for anthelmintics.

Authors:  Robert M Greenberg
Journal:  Curr Clin Microbiol Rep       Date:  2014-12

8.  Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.

Authors:  Wei Wang; Tian-Yu Li; Yuan Ji; Guo-Li Qu; Yi-Li Qian; Hong-Jun Li; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-12-11       Impact factor: 2.289

Review 9.  Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.

Authors:  Chiuan Yee Leow; Charlene Willis; Andreas Hofmann; Malcolm K Jones
Journal:  Br J Pharmacol       Date:  2014-12-23       Impact factor: 8.739

10.  Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.

Authors:  Claudia L L Valentim; Donato Cioli; Frédéric D Chevalier; Xiaohang Cao; Alexander B Taylor; Stephen P Holloway; Livia Pica-Mattoccia; Alessandra Guidi; Annalisa Basso; Isheng J Tsai; Matthew Berriman; Claudia Carvalho-Queiroz; Marcio Almeida; Hector Aguilar; Doug E Frantz; P John Hart; Philip T LoVerde; Timothy J C Anderson
Journal:  Science       Date:  2013-11-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.